FIREFISH Parts 1 and 2: 24-month Safety and Efficacy of Risdiplam in Type 1 SMA

被引：0

作者：

Darras, Basil T. ^{[1
]}

Boespflug-Tanguy, Odile ^{[2
,3
]}

Day, John W. ^{[4
]}

Deconinck, Nicolas ^{[5
,6
]}

Klein, Andrea ^{[7
,8
]}

Masson, Riccardo ^{[9
]}

Mazurkiewicz-Beldzinska, Maria ^{[10
]}

Mercuri, Eugenio ^{[11
,12
]}

Rose, Kristy ^{[13
]}

Servais, Laurent ^{[2
,14
,15
,16
]}

Vlodavets, Dmitry ^{[17
]}

Xiong, Hui ^{[18
]}

Zanoteli, Edmar ^{[19
]}

Dodman, Angela ^{[20
]}

El-Khairi, Muna ^{[21
]}

Gaki, Eleni ^{[21
]}

Gerber, Marianne ^{[22
]}

Gorni, Ksenija ^{[23
]}

Kletzl, Heidemarie ^{[24
]}

Baranello, Giovanni ^{[9
,25
,26
]}

机构：

[1] Harvard Med Sch, Boston Childrens Hosp, Dept Neurol, Boston, MA 02115 USA

[2] Hop Armand Trousseau, I Mot, Paris, France

[3] Univ Paris, NeuroDiderot, UMR 1141, Paris, France

[4] Stanford Univ, Dept Neurol, Stanford, CA 94305 USA

[5] UZ Gent, Neuromuscular Reference Ctr, Ghent, Belgium

[6] ULB, Ctr Reference Malad Neuromusculaires, Queen Fabiola Childrens Univ Hosp, Brussels, Belgium

[7] Univ Childrens Hosp Basel, Paediat Neurol, Basel, Switzerland

[8] Univ Bern, Inselspital, Paediat Neurol, Bern, Switzerland

[9] Fdn IRCCS Ist Neurol Carlo Besta, Dev Neurol Unit, Milan, Italy

[10] Med Univ Gdansk, Dept Dev Neurol, Gdansk, Poland

[11] Catholic Univ, Pediat Neurol Inst, Washington, DC USA

[12] Fdn Policlin Gemelli IRCCS, Nemo Pediat, Rome, Italy

[13] Childrens Hosp Westmead, Paediat Gait Anal Serv New South Wales, Westmead, NSW, Australia

[14] MDUK Oxford Neuromuscular Ctr, Dept Paediat, Oxford, England

[15] Univ Hosp Liege, Ctr References Malad Neuromusculaires, Dept Pediat, Div Child Neurol, Liege, Belgium

[16] Univ Liege, Liege, Belgium

[17] Pirogov Russian Natl Res Med Univ, Russian Children Neuromuscular Ctr, Veltischev Clin Pediat Res Inst, Moscow, Russia

[18] Peking Univ First Hosp, Dept Pediat, Beijing, Peoples R China

[19] Univ Sao Paulo, Fac Med, Dept Neurol, FMUSP, Sao Paulo, Brazil

[20] F Hoffmann La Roche Ltd, Pharma Dev Neurol, Basel, Switzerland

[21] Roche Prod Ltd, Welwyn Garden City, Herts, England

[22] F Hoffmann La Roche Ltd, Pharma Dev Safety, Basel, Switzerland

[23] F Hoffmann La Roche Ltd, PDMA Neurosci & Rare Dis, Basel, Switzerland

[24] Roche Innovat Ctr Basel, Roche Pharmaceut Res & Early Dev, Basel, Switzerland

[25] UCL, NIHR Great Ormond St Hosp Biomed Res Ctr, Great Ormond St Inst Child Hlth, Dubowitz Neuromuscular Ctr, London, England

[26] Great Ormond St Hosp Trust, London, England

来源：

NEUROLOGY | 2022年 / 98卷 / 18期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

S39.005

引用

页数：6

共 50 条

[21] EFFICACY AND SAFETY OF LUMASIRAN IN PATIENTS WITH PRIMARY HYPEROXALURIA TYPE 1: 24-MONTH ANALYSIS OF THE ILLUMINATE-A TRIAL
Lieske, John
Groothoff, Jaap
Frishberg, Yaacov
Sellier-Leclerc, Anne-Laure
Shasha-Lavsky, Hadas
Saland, Jeffrey
Hayes, Wesley
Magen, Daniella
Moochhala, Shabbir
Coenen, Martin
Simkova, Eva
Ngo, Taylor
Gansner, John
Hulton, Sally-Anne
JOURNAL OF UROLOGY, 2022, 207 (05): : E87 - E87
[22] EFFICACY AND SAFETY OF LUMASIRAN IN PATIENTS WITH PRIMARY HYPEROXALURIA TYPE 1: 24-MONTH ANALYSIS OF THE ILLUMINATE-A TRIAL
Lieske, John
Groothoff, Jaap
Frishberg, Yaacov
Sellier-Leclerc, Anne-Laure
Shasha-Lavsky, Hadas
Saland, Jeffrey
Hayes, Wesley
Magen, Daniella
Moochhala, Shabbir
Coenen, Martin
Simkova, Eva
Ngo, Taylor
Gansner, John
Hulton, Sally-Anne
AMERICAN JOURNAL OF KIDNEY DISEASES, 2022, 79 (04) : S1 - S2
[23] Sunfish parts 1 and 2: 4-year efficacy and safety data of risdiplam in types 2 and 3 spinal muscular atrophy (SMA)
Oskoui, Maryam
Deconinck, Nicolas
Mazzone, Elena S.
Nascimento, Andres
Day, John W.
Saito, Kayoko
Vuillerot, Carole
Baranello, Giovanni
Boespflug-Tanguy, Odile
Goemans, Nathalie
Kirschnero, Janbernd
Kostera-Pruszczyk, Anna
Servais, Laurent
Braid, Jessica
Gerber, Marianne
Gorni, Ksenija
Martin, Carmen
Yeung, Wai Yin
Scalco, Renata S.
Mercuri, Eugenio
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 455
[24] SUNFISH Parts 1 and 2: 4-year Efficacy and Safety Data of Risdiplam in Types 2 and 3 Spinal Muscular Atrophy (SMA)
Servais, Laurent
Oskoui, Maryam
Day, John
Deconinck, Nicholas
Mazzone, Elena
Nascimento, Andres
Saito, Kyoko
Vuillerot, Carole
Baranello, Giovanni
Boespflug-Tanguy, Odile
Goemans, Nathalie
Kirschner, Janbernd
Kostera-Pruszczyk, Anna
Braid, Jessica
Papp, Gergely
Gorni, Ksenija
Martin, Carmen
Scalco, Renata
Yeung, Wai Yin
Mercuri, Eugenio
NEUROLOGY, 2023, 100 (17)
[25] SUNFISH Parts 1 and 2: 4-year efficacy and safety data of risdiplam in Types 2 and 3 spinal muscular atrophy (SMA)
Kostera-Pruszczyk, A.
Day, J.
Deconinck, N.
Mazzone, E.
Nascimento, A.
Oskoui, M.
Saito, K.
Vuillerot, C.
Baranello, G.
Boespflug-Tanguy, O.
Goemans, N.
Kirschner, J.
Servais, L.
Braid, J.
Gerber, M.
Gorni, K.
Martin, C.
Yeung, W.
Scalco, R.
Mercuri, E.
EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 194 - 194
[26] FIREFISH Part 1: 16-month safety and exploratory outcomes of risdiplam (RG7916) treatment in infants with type 1 spinal muscular atrophy
Baranello, G.
Servais, L.
Day, J.
Deconinck, N.
Mercuri, E.
Klein, A.
Darras, B.
Masson, R.
Kletzl, H.
Cleary, Y.
El-Khairi, M.
Seabrook, T.
Czech, C.
Gerber, M.
Nguyen, C.
Gelblin, K.
Gorni, K.
NEUROMUSCULAR DISORDERS, 2019, 29 : S184 - S184
[27] Safety and efficacy of risdiplam in patients with type 1 spinal muscular atrophy (FIREFISH part 2): secondary analyses from an open-label trial
Masson, Riccardo
Mazurkiewicz-Beldzinska, Maria
Rose, Kristy
Servais, Laurent
Xiong, Hui
Zanoteli, Edmar
Baranello, Giovanni
Bruno, Claudio
Day, John W.
Deconinck, Nicolas
Klein, Andrea
Mercuri, Eugenio
Vlodavets, Dmitry
Wang, Yi
Dodman, Angela
El-Khairi, Muna
Gorni, Ksenija
Jaber, Birgit
Kletzl, Heidemarie
Gaki, Eleni
Fontoura, Paulo
Darras, Basil T.
LANCET NEUROLOGY, 2022, 21 (12): : 1110 - 1119
[28] FIREFISH Part 1: survival, ventilation and swallowing ability in infants with type 1 spinal muscular atrophy (SMA) treated with risdiplam (RG7916)
Vlodavets, D.
Servais, L.
Baranello, G.
Day, J. W.
Deconinck, N.
Mercuri, E.
Klein, A.
Darras, B.
Masson, R.
Kletzl, H.
Cleary, Y.
El-Khairi, M.
Seabrook, T.
Czech, C.
Gerber, M.
Nguyen, C.
Gelblin, K.
Gorni, K.
Khwaja, O.
EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 310 - 311
[29] Age and baseline values predict 12 and 24-month functional changes in type 2 SMA
Coratti, Giorgia
Pera, Maria C.
Lucibello, Simona
Montes, Jacqueline
Pasternak, Amy
Mayhew, Anna
Glanzman, Allan M.
Young, Sally Dunaway
Pane, Marika
Scoto, Mariacristina
Messina, Sonia
Goemans, Nathalie
Osorio, Andres Nascimiento
Pedemonte, Marina
Sansone, Valeria
Bertini, Enrico
De Vivo, Darryl C.
Finkel, Richard
Muntoni, Francesco
Mercuri, Eugenio
NEUROMUSCULAR DISORDERS, 2020, 30 (09) : 756 - 764
[30] Long-term comparative efficacy and safety of risdiplam versus nusinersen in children with Type 1 spinal muscular atrophy (SMA)
Sajeev, G.
Evans, R.
Hawkins, N.
Mahajan, A.
Scott, D.
Nam, J.
Sutherland, S.
Kokaliaris, C.
NEUROMUSCULAR DISORDERS, 2023, 33 : S164 - S164

← 1 2 3 4 5 →